Zurich Cantonal Bank
RIGL icon

Zurich Cantonal Bank’s Rigel Pharmaceuticals RIGL Stock Holding History

Zurich Cantonal Bank’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.7K Buy
632
+297
+89% +$9.16K ﹤0.01% 2475
2026
Q1 		$9.06K Buy
+335
New +$11.3K ﹤0.01% 2485
2025
Q4 		– Sell
-461
Closed -$17.4K – 3321
2025
Q3 		$13.1K Sell
461
-202
-30% -$6.04K ﹤0.01% 2488
2025
Q2 		$12.4K Sell
663
-73
-10% -$1.38K ﹤0.01% 2506
2025
Q1 		$13.2K Buy
+736
New +$14.9K ﹤0.01% 2574
2022
Q4 		– Sell
-2,669
Closed -$31K – 2894
2022
Q3 		$31K Hold
2,669
– – ﹤0.01% 2722
2022
Q2 		$30K Hold
2,669
– – ﹤0.01% 2727
2022
Q1 		$80K Sell
2,669
-1,577
-37% -$42.7K ﹤0.01% 2375
2021
Q4 		$113K Sell
4,246
-159
-4% -$4.8K ﹤0.01% 2442
2021
Q3 		$160K Buy
4,405
+51
+1% +$2.01K ﹤0.01% 2068
2021
Q2 		$189K Buy
4,354
+826
+23% +$31.2K ﹤0.01% 1847
2021
Q1 		$121K Sell
3,528
-1,627
-32% -$64.4K ﹤0.01% 2052
2020
Q4 		$180K Buy
5,155
+4,177
+427% +$121K ﹤0.01% 1917
2020
Q3 		$23K Hold
978
– – ﹤0.01% 2470
2020
Q2 		$18K Hold
978
– – ﹤0.01% 2474
2020
Q1 		$15K Hold
978
– – ﹤0.01% 2414
2019
Q4 		$21K Hold
978
– – ﹤0.01% 2492
2019
Q3 		$18K Hold
978
– – ﹤0.01% 2476
2019
Q2 		$26K Hold
978
– – ﹤0.01% 2380
2019
Q1 		$25K Sell
978
-892
-48% -$20.4K ﹤0.01% 2351
2018
Q4 		$43K Hold
1,870
– – ﹤0.01% 2127
2018
Q3 		$60K Buy
1,870
+605
+48% +$18.2K ﹤0.01% 2048
2018
Q2 		$36K Buy
+1,265
New +$45K ﹤0.01% 2287

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Zurich Cantonal Bank's RIGL Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Rigel Pharmaceuticals (RIGL) stake by 89% in Q2 2026, buying an estimated $9.16K and bringing the position to 632 shares worth $24.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2475.

Zurich Cantonal Bank first reported a position in RIGL in Q2 2018 and has held it in 23 quarters since. The position peaked at $189K in Q2 2021. 155 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Zurich Cantonal Bank held 632 shares of Rigel Pharmaceuticals worth $24.7K as of Q2 2026.
  • Zurich Cantonal Bank bought 297 Rigel Pharmaceuticals shares in Q2 2026, an estimated $9.16K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2475 holding.
  • Zurich Cantonal Bank first reported a position in Rigel Pharmaceuticals in Q2 2018 and has held it in 23 quarters since.
  • Zurich Cantonal Bank's Rigel Pharmaceuticals position peaked at $189K in Q2 2021.
  • 155 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.